Colgate-Palmolive posted a higher profit in the first quarter but lowered 2025 earnings guidance due to tariffs.

Calling all income investors! Two dividend kinds deserve your attention in 2025: Colgate-Palmolive (NYSE:CL) and Emerson ...

JP Morgan analyst Andrea Teixeira maintained Colgate-Palmolive with an Overweight rating and raised the price target from $95 ...

We look at Colgate-Palmolive Company's Q1 results, market challenges, and tariff impacts. Read to see if the CL stock is ...

The owner of skin care brand Sanex is also expecting a price hike on sold goods as a result of US President Donald Trump’s ...

Colgate-Palmolive on Friday reported better-than-expected first-quarter results and lifted its full-year sales outlook, ...

Organic sales rose 1.4% during the quarter, with pricing up 1.5% and volume down 0.1%. The impact of FX was a negative 4.4% ...

Colgate-Palmolive surpassed earnings expectations in Q1 2025, despite experiencing a decline in overall sales.

April 25 (Reuters) - Colgate-Palmolive (CL.N), opens new tab reported quarterly results that beat Wall Street estimates and raised its annual sales forecast on Friday, banking on moderate price ...

Colgate-Palmolive alum Elaine Paik will step into the skincare brand’s top financial seat and will also lead the company’s ...

Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more ...

Higher costs could further dampen consumer demand. For Colgate, tariffs will drive raw and packaging materials costs higher ...